EXPRESSION OF SYNAPTIC VESICLE PROTEIN 2A (SV2A), THE BINDING SITE FOR LEVETIRACETAM, IN EPILEPSY-ASSOCIATED BRAIN TUMORS AND IN THE PERILESIONAL EPILEPTIC CORTEX

被引:0
|
作者
Toering, S. T. [1 ]
Boer, K. [2 ]
Heimans, J. J. [1 ]
Aronica, E. [2 ]
Reijneveld, J. C. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1147 / 1147
页数:1
相关论文
共 50 条
  • [21] Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer's disease: a radioligand binding study in postmortem brains
    Mikkelsen, Jens D.
    Kaad, Sif
    Aripaka, Sanjay S.
    Finsen, Bente
    NEUROBIOLOGY OF AGING, 2023, 129 : 50 - 57
  • [22] Inhibition of Ca2+-regulated exocytosis by levetiracetam in guinea-pig antral mucous cells: role of synaptic vesicle protein 2A, SV2A
    Harada, Saeko
    Shimamoto, Chikao
    Matsumura, Hitoshi
    Kohda, Yuka
    Tanaka, Saori
    Nakahari, Takashi
    FASEB JOURNAL, 2012, 26
  • [23] Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes
    Hayashi, M
    Yatsushiro, S
    Yamada, H
    Yamamoto, A
    Futai, M
    Yamaguchi, A
    Moriyama, Y
    MELATONIN AFTER FOUR DECADES: AN ASSESSMENT OF ITS POTENTIAL, 1999, 460 : 91 - 93
  • [24] Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes
    Hayashi, T
    Yamamoto, A
    Yatsushiro, S
    Yamada, H
    Futai, M
    Yamaguchi, A
    Moriyama, Y
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (01) : 356 - 365
  • [25] Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events
    Michele Romoli
    Martina Mandarano
    Marina Romozzi
    Paolo Eusebi
    Chiara Bedetti
    Elena Nardi Cesarini
    Angela Verzina
    Carmen Calvello
    Elisabetta Loreti
    Angelo Sidoni
    Paolo Giovenali
    Paolo Calabresi
    Cinzia Costa
    Journal of Neurology, 2019, 266 : 2273 - 2276
  • [26] Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events
    Romoli, Michele
    Mandarano, Martina
    Romozzi, Marina
    Eusebi, Paolo
    Bedetti, Chiara
    Cesarini, Elena Nardi
    Verzina, Angela
    Calvello, Carmen
    Loreti, Elisabetta
    Sidoni, Angelo
    Giovenali, Paolo
    Calabresi, Paolo
    Costa, Cinzia
    JOURNAL OF NEUROLOGY, 2019, 266 (09) : 2273 - 2276
  • [27] Pathophysiological alterations of synaptic vesicle protein 2A (SV2A) in Groggy rat, a rat model of absence seizure.
    Okumura, Takahiro
    Ishihara, Shizuka
    Terada, Ryo
    Tomita, Chisato
    Kitaya, Ryosuke
    Tokudome, Kentarou
    Tanaka, Tomoya
    Shimizu, Saki
    Kawai, Yoshiko
    Serikawa, Tadao
    Sasa, Masashi
    Ohno, Yukihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 150P - 150P
  • [28] Synaptic vesicle protein 2A. Involvement in epilepsy-associated processes and interactions with anticonvulsants
    Surges, R.
    Schoch, S.
    Elger, C. E.
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2012, 25 (03): : 215 - 221
  • [29] Differential expression of synaptic vesicle protein 2A in epileptic human cortical dysplasia
    Alexopoulos, AV
    Tilelli, CQ
    Oghlakian, RO
    Gonzalez-Martinez, J
    Bingaman, WE
    Najm, IM
    EPILEPSIA, 2005, 46 : 273 - 274
  • [30] Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer's Disease Patients
    Metaxas, Athanasios
    Thygesen, Camilla
    Briting, Sanne R. R.
    Landau, Anne M.
    Darvesh, Sultan
    Finsen, Bente
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13